Anne Michel
CEO, HERMIONE THERAPEUTICS
Hermione Therapeutics develops a game changer platform enabling bacterial biofilm dispersion. ANP is our 1st lead as smart companion enhancing SoC antibiotics and preventing dose escalation in chronic respiratory diseases.
Events Anne Michel has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026